Company Overview
Profit after Tax
N/A
Cr
Growth:
N/A
Industry P/S: N/A
Fundamentals
| Sales (Cr) |
₹ N/A |
| Growth |
N/A |
| EBITDA |
N/A |
| P/S |
N/A |
| Dividend |
N/A |
| P/E |
N/A |
| Book Value |
₹ N/A |
| PEG Ratio |
N/A |
| ROE |
N/A |
| P/B |
N/A |
Shareholding Pattern
Increase
Decrease
No change
The company is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer.
